This study identified a synergistic combination of inhibitors for KIF11 (SB-743921) and AURKA (VIC-1911) that demonstrated significant pre-clinical activity in vitro and efficacy in an in vivo xenograft mouse model of Ewing sarcoma. Here, KIF11 is linked to Ewing sarcoma.